Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors

Colin O'Dowd, Matthew Helm, shane rountree, Jakub T. Flasz, Elias Arkoudis, hugues miel, peter hewitt, linda jordan, oliver barker, caroline hughes, ewelina rozycka, eamon cassidy, keeva mcclelland, ewa odrzywol, natalie page, stephanie fuetren-burton, Scarlett Dvorkin, gerald gavory, Timothy Harrison

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)
220 Downloads (Pure)

Abstract

Ubiquitin specific protease 7 (USP7, HAUSP) has become an attractive target in drug discovery due to the role it plays in modulating Mdm2 levels and consequently p53. Increasing interest in USP7 is emerging due to its potential involvement in oncogenic pathways as well as possible roles in both metabolic and immune disorders in addition to viral infections. Potent, novel and selective inhibitors of USP7 have been developed using both rational and structure-guided design enabled by high resolution co-crystallography. Initial hits were identified via fragment-based screening, scaffold-hopping and hybridization exercises. Two distinct sub-series are described along with associated SAR trends, as are initial efforts aimed at developing compounds suitable for in vivo experiments. Overall these discoveries will enable further research into the wider biological role of USP7.
Original languageEnglish
Pages (from-to)238-243
JournalACS MEDICINAL CHEMISTRY LETTERS
Volume9
Issue number3
Early online date21 Feb 2018
DOIs
Publication statusEarly online date - 21 Feb 2018

Fingerprint Dive into the research topics of 'Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors'. Together they form a unique fingerprint.

Cite this